Abstract | OBJECTIVES: METHODS/RESULTS: Belween 1997--2003 30 procedures of periurethral injection of various substances for urinary incontinence were performed at our department in women between 47-80 years. All patients were evaluated before surgery, clinically and urodynamically, in accordance to international standardized parameters (filling pressure/flow studies, maximum urethral closure pressure, LPP-leak point pressure). The kind of material employed for injection, surgical technique and satisfaction degree were also evaluated. RESULTS: The indication for surgery was SUI in 17 cases (56.6%), and mixed urinary incontinence in 73 cases (43.3%). 16 cases (53.3%) had history of previous surgery for SUI. Regarding urodynamic parameters, 19 patients (63.3%) have a maximum urethral closure pressure below 25 H2O cm, and 22 patients (73.3%) had a leak point pressure below 60 H2O cm. Collagen was employed in six cases (20%) and macroplastic in 24 (80%) (14 of them with the MIS system). 22 patients had three injection sites (73.3%). Mean follow-up was 38 months. Continence outcomes were evaluated in relation to complete continence (12 cases, 40%), mild incontinence and patient satisfaction (11 cases, 36.6%), and severe incontinence (7 cases, 23.3%). CONCLUSIONS: 1-To achieve acceptable results it is mandatory to do the best possible indication (Mc Guire type III SUI). 2.-There is an excellent relationship between minimal invasiveness and good results.
|
Authors | Oscar Rodríguez Faba, Alfonso San Martín Blanco, Antonio Jalón Monzón, Roberto Carlos González Alvarez, Miguel Alvarez Mújica, Jesús Ma Férnández Gómez, José Luis Martín Benito, Safwan Escaf Barmadah, Javier Regaderas Sejas |
Journal | Archivos espanoles de urologia
(Arch Esp Urol)
Vol. 58
Issue 3
Pg. 227-31
(Apr 2005)
ISSN: 0004-0614 [Print] Spain |
Vernacular Title | "Tratamiento de la incontinencia urinaria mediante sustancias inyectables. Análisis de nuestra serie". |
PMID | 15906616
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Biocompatible Materials
(administration & dosage)
- Female
- Humans
- Injections
- Middle Aged
- Urinary Incontinence
(therapy)
|